Literature DB >> 23983832

A proposed roadmap for inpatient neurology quality indicators.

Vanja C Douglas1, S Andrew Josephson.   

Abstract

BACKGROUND/
PURPOSE: In recent years, there has been increasing pressure to measure and report quality in health care. However, there has been little focus on quality measurement in the field of neurology for conditions other than stroke and transient ischemic attack. As the number of evidence-based treatments for neurological conditions grows, so will the demand to measure the quality of care delivered. The purpose of this study was to review essential components of hospital performance measures for neurological disease and propose potential quality indicators for commonly encountered inpatient neurological diagnoses.
METHODS: We determined the most common inpatient neurological diagnoses at a major tertiary care medical center by reviewing the billing database. We then searched PubMed and the National Guidelines Clearinghouse to identify treatment guidelines for these conditions. Guideline recommendations with class I/level A evidence were evaluated as possible quality indicators.
RESULTS: We found 94 guidelines for 14 inpatient neurological conditions other than stroke and transient ischemic attack. Of these, 36 guidelines contained at least 1 recommendation with class I evidence. Based on these, potential quality indicators for intracerebral hemorrhage, subarachnoid hemorrhage, pneumococcal meningitis, coma following cardiac arrest, encephalitis, Guillain-Barre syndrome, multiple sclerosis, and benign paroxysmal positional vertigo are proposed.
CONCLUSIONS: There are several inpatient neurological conditions with treatments or diagnostic test routines supported by high levels of evidence that could be used in the future as quality indicators.

Entities:  

Keywords:  brain; central nervous system diseases; cerebrovascular disorders; epidemiology; hypoxia-ischemia; intracranial hemorrhages; outcomes; stroke delirium

Year:  2011        PMID: 23983832      PMCID: PMC3726101          DOI: 10.1177/1941875210380676

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  44 in total

1.  Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S D Silberstein
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

Review 2.  Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  E F M Wijdicks; A Hijdra; G B Young; C L Bassetti; S Wiebe
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

3.  Guidelines for the use of hypothermia after cardiac arrest.

Authors: 
Journal:  CJEM       Date:  2006-03       Impact factor: 2.410

4.  EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses.

Authors:  F Sellebjerg; D Barnes; G Filippini; R Midgard; X Montalban; P Rieckmann; K Selmaj; L H Visser; P S Sørensen
Journal:  Eur J Neurol       Date:  2005-12       Impact factor: 6.089

Review 5.  Viral encephalitis: a review of diagnostic methods and guidelines for management.

Authors:  I Steiner; H Budka; A Chaudhuri; M Koskiniemi; K Sainio; O Salonen; P G E Kennedy
Journal:  Eur J Neurol       Date:  2005-05       Impact factor: 6.089

6.  Management of alcohol withdrawal delirium. An evidence-based practice guideline.

Authors:  Michael F Mayo-Smith; Lee H Beecher; Timothy L Fischer; David A Gorelick; Jeanette L Guillaume; Arnold Hill; Gail Jara; Chris Kasser; John Melbourne
Journal:  Arch Intern Med       Date:  2004-07-12

Review 7.  Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  D S Goodin; B A Cohen; P O'Connor; L Kappos; J C Stevens
Journal:  Neurology       Date:  2008-09-02       Impact factor: 9.910

8.  Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R A C Hughes; E F M Wijdicks; R Barohn; E Benson; D R Cornblath; A F Hahn; J M Meythaler; R G Miller; J T Sladky; J C Stevens
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

9.  EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.

Authors:  I Elovaara; S Apostolski; P van Doorn; N E Gilhus; A Hietaharju; J Honkaniemi; I N van Schaik; N Scolding; P Soelberg Sørensen; B Udd
Journal:  Eur J Neurol       Date:  2008-09       Impact factor: 6.089

10.  Canadian Association of Emergency Physicians Guidelines for the acute management of migraine headache.

Authors:  J Ducharme
Journal:  J Emerg Med       Date:  1999 Jan-Feb       Impact factor: 1.484

View more
  6 in total

1.  Advances in epilepsy in 2013 for the neurohospitalist.

Authors:  Andrew Nathan Wilner
Journal:  Neurohospitalist       Date:  2014-04

2.  Hospital admission and readmission among homeless patients with neurologic disease.

Authors:  Nicole Rosendale; Elan L Guterman; John P Betjemann; S Andrew Josephson; Vanja C Douglas
Journal:  Neurology       Date:  2019-05-24       Impact factor: 9.910

3.  Neurohospitalist: A newly popular career choice.

Authors:  S Andrew Josephson; Vanja C Douglas
Journal:  Neurol Clin Pract       Date:  2011-12

4.  Assessing Four Quality Indicators for Multiple Sclerosis Management Through Patient-Reported Data.

Authors:  Sarah J Shoemaker; Alyssa Pozniak; Louise Hadden
Journal:  Int J MS Care       Date:  2016 Jul-Aug

Review 5.  Neurohospitalists: an emerging subspecialty.

Authors:  Ira Chang; Robert W Pratt
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

6.  Focusing on transitions of care: A change is here.

Authors:  S Andrew Josephson
Journal:  Neurol Clin Pract       Date:  2016-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.